<DOC>
	<DOCNO>NCT02683707</DOCNO>
	<brief_summary>With potent analgesic property , perceive hemodynamic benefit limited alternative , opiates analgesic mainstay acute coronary syndrome ( ACS ) patient report peri-procedural pain nitrate-resistant chest pain . However , large observational study suggest opiate administration ACS may result adverse cardiovascular outcome . Complimenting , number recent mechanistic study demonstrate delay attenuated effect oral dual anti-platelet therapy ( DAPT ) platelet inhibition endpoint among subject receive intravenous morphine . These study support hypothesis morphine delay gastrointestinal absorption DAPT medication . However , data exist impact intravenous fentanyl , systemic opioid analgesic routinely administer percutaneous coronary intervention ( PCI ) procedure , platelet inhibition effect DAPT . The investigator hypothesize , similar morphine , fentanyl administer time PCI reduce delay effect DAPT platelet function . As , primary aim study test impact intravenous fentanyl residual platelet reactivity randomize patient undergo PCI strategy peri-procedural benzodiazepine plus non-systemic local analgesia current standard benzodiazepine plus intravenous fentanyl . Given critical need rapid robust inhibition platelet function PCI , trial true potential change clinical practice , particularly investigator demonstrate reduce DAPT absorption elevate residual platelet reactivity among patient receive fentanyl PCI .</brief_summary>
	<brief_title>The Platelet Aggregation After tiCagrelor Inhibition FentanYl Trial ( PACIFY )</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>undergo clinically indicate PCI ; &gt; 18 year age ; able PO medication provide inform consent pregnant ; DAPT ( clopidogrel , prasugrel , ticagrelor ) within 14 day enrollment ; know coagulation disorder ; active treatment oral anticoagulant low molecular weight heparin ; impaired renal hepatic function ; platelet &lt; 100 x10 3 /mcl ; plan use Glycoprotein 2b3a PCI ; Prior Trans Arterial Valve Replacement ( TAVR ) plan TAVR post PCI ; contraindication ticagrelor opiate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Percutaneous Coronary Intervention</keyword>
	<keyword>Blood Platelets</keyword>
	<keyword>Fentanyl</keyword>
</DOC>